AusPAR: Inactivated influenza virus vaccine (containing 15 μg haemagglutinin of virus Types A H1N1+ A H3N2 + B)
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
15 September 2015
| AusPAR | |
|---|---|
| Active Ingredient | Inactivated influenza virus vaccine (containing 15 μg haemagglutinin of virus Types A H1N1+ A H3N2 + B)
|
| Product Name | Optaflu
|
| Sponsor | Novartis Vaccines & Diagnostics Pty Ltd
|
| Submission Number | PM-2013-04969-1-2
|
| Submission Type | New chemical entity
|
| Decision | Approved
|
| AusPAR Date | 24 August 2015
|
| Publication Date | 15 September 2015 |